PureCycle Technologies Future Growth
Future criteria checks 2/6
PureCycle Technologies is forecast to grow earnings and revenue by 60.5% and 66.6% per annum respectively while EPS is expected to grow by 52.2% per annum.
Key information
60.5%
Earnings growth rate
52.2%
EPS growth rate
Chemicals earnings growth | 16.8% |
Revenue growth rate | 66.6% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 20 Nov 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 199 | -94 | -241 | -46 | 4 |
12/31/2025 | 94 | -108 | -261 | -85 | 5 |
12/31/2024 | 7 | -259 | -159 | -124 | 3 |
9/30/2024 | N/A | -253 | -192 | -147 | N/A |
6/30/2024 | N/A | -154 | -188 | -134 | N/A |
3/31/2024 | N/A | -161 | -241 | -119 | N/A |
12/31/2023 | N/A | -102 | -249 | -95 | N/A |
9/30/2023 | N/A | -82 | -294 | -77 | N/A |
6/30/2023 | N/A | -126 | -355 | -71 | N/A |
3/31/2023 | N/A | -85 | -345 | -63 | N/A |
12/31/2022 | N/A | -85 | -353 | -65 | N/A |
9/30/2022 | N/A | -95 | -324 | -63 | N/A |
6/30/2022 | N/A | -81 | -269 | -55 | N/A |
3/31/2022 | N/A | -77 | -207 | -51 | N/A |
12/31/2021 | N/A | -78 | -192 | -55 | N/A |
9/30/2021 | N/A | -94 | -165 | -49 | N/A |
6/30/2021 | N/A | -81 | -124 | -45 | N/A |
3/31/2021 | N/A | -75 | -97 | -34 | N/A |
12/31/2020 | N/A | -56 | -48 | -18 | N/A |
9/30/2020 | N/A | -24 | -15 | -9 | N/A |
12/31/2019 | N/A | -22 | -12 | -6 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PCT is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: PCT is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: PCT is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: PCT's revenue (66.6% per year) is forecast to grow faster than the US market (8.9% per year).
High Growth Revenue: PCT's revenue (66.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PCT's Return on Equity is forecast to be high in 3 years time